Table 2. The Cb-specific IgG titers of the patients detected by IFA.

Patient	In-patient date	Out-patient date	Age	Sex	Acute plasma		Convalescent plasma		Serum-positive
			(years)		Phase I IgG	Phase II IgG	Phase I IgG	Phase II IgG
1	2018/12/31	2019/1/10	42	male	<25	<25	100	100	P
2	2019/1/1	2019/1/10	35	male	<25	100	≥800	≥800	P
3	2018/12/31	2019/1/15	45	male	<25	<25	400	400	P
4	2018/12/31	2019/1/5	57	male	100	100	≥800	≥800	P
5	2018/12/31	2019/1/5	47	male	<25	<25	100	<25	P
6	2019/1/6	2019/1/12	53	male	<25	<25	400	400	P
7	2019/1/3	2019/1/10	43	male	<25	<25	200	200	P
8	2019/1/7	2019/1/14	52	male	<25	<25	400	≥800	P
9	2019/1/7	2019/1/14	40	male	<25	<25	200	200	P
10	2019/1/7	2019/1/10	51	male	<25	<25	400	400	P
11	2019/1/10	2019/1/15	59	male	<25	<25	100	400	P
12	2019/1/13	2019/1/18	43	male	<25	100	400	≥800	P
13	2019/1/11	2019/1/13	54	male	<25	<25	≥800	≥800	P
14	2019/1/13	2019/1/17	43	male	400	400	NA	NA	P
15	2019/1/14	2019/1/18	30	male	200	200	NA	NA	P
16	2019/1/10	2019/1/18	52	male	100	100	NA	NA	P
17	2019/1/15	2019/1/28	42	male	100	200	NA	NA	P
18	2019/1/15	2019/1/21	29	male	<25	100	NA	NA	P
19	2019/1/14	2019/1/16	37	male	100	100	NA	NA	P
20	2019/1/14	2019/1/18	33	male	<25	100	NA	NA	P
21	2019/1/14	2019/1/19	41	male	<25	200	NA	NA	P
22	2019/1/16	2019/1/18	40	male	400	400	NA	NA	P
23	2019/1/20	2019/1/30	46	male	200	200	NA	NA	P
24	2019/1/19	2019/1/24	57	male	100	100	NA	NA	P
25	2019/1/18	2019/1/22	53	male	100	<25	NA	NA	N
26	2019/1/18	2019/1/22	22	male	200	200	NA	NA	P
27	2019/1/19	2019/1/24	55	male	400	400	NA	NA	P
28	2019/1/26	2019/1/29	39	male	<25	<25	NA	NA	N
29	2019/1/29	2019/2/2	46	male	<25	<25	NA	NA	N
30	2019/1/30	2019/2/2	27	male	<25	<25	NA	NA	N
31	2019/1/30	2019/2/1	26	male	<25	<25	NA	NA	N
32	2019/1/29	2019/2/1	31	male	<25	<25	NA	NA	N
33	2019/1/30	2019/2/3	35	male	<25	<25	NA	NA	N
34	2019/1/30	2019/2/3	49	male	<25	<25	NA	NA	N
35	2019/1/30	2019/2/2	36	male	<25	<25	NA	NA	N
36	2019/1/30	2019/2/2	33	male	<25	<25	NA	NA	N

P, positive; N, negative; NA, not collected.